Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker, L. Grote, G. Johannsson, J. Hedner (Skövde, Gothenburg, Sweden). Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea. Eur Respir J 2006; 28: Suppl. 50, 1707

Member's Comments

No comment yet.

Related content which might interest you: Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 The state and responsiveness of the renin-angiotensin-aldosterone system in obstructive sleep apnoea Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003 Comparisson of corrective effects of APAP and CPAP on disordered autonomic nervous system function in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Impact of continuous positive airways pressure treatment on autonomic nervous system activity in patients with sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 The relation between obstructive apneas in OSA patients and autonomic activity Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Sympathetic activity at rest and during exercise in metabolic syndrome subjects with and without obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 The efficacy of sidenafil and CPAP in men with obstructive sleep apnea syndrome and erectile dysfunction Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex Source: Eur Respir J 2003; 21: 241-247 Year: 2003 Non-dipping nocturnal blood pressure correlates with obstructive sleep apnoea severity in normotensive subjects and may reverse with therapy Source: ERJ Open Res, 7 (3) 00338-2021; 10.1183/23120541.00338-2021 Year: 2021 Influence of treatment on leptin levels in patients with obstructive sleep apnoea Source: Eur Respir J 2004; 23: 601-604 Year: 2004 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Efficacy of an automatic positive airway pressure system for treatment of obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002 Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Effects of autoCPAP treatment for obstructive sleep apnea on 24-hour blood pressure and nocturnal catecholamines Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002